The global pet dental health market is projected to grow from an estimated value of $8.80 billion in 2025 to $20.10 billion by 2036, achieving a compound annual growth rate (CAGR) of 7.8% during the period from 2026 to 2036, according to a report by Fact.MR.
Read More
The market encompasses a wide array of products, including dental chews, rawhide dental chews, non-rawhide dental chews, and other therapeutic items aimed at dogs and small breed dogs. This growth is attributed to the increasing prevalence of dental diseases in pets, enhancing clinical evidence, and greater healthcare accessibility in both developed and emerging markets.
Key growth drivers include rising diagnosis rates, regulatory approvals, and expansions in payer coverage, which collectively contribute to sustained demand over the forecast period. The report highlights that the dental chews segment is anticipated to dominate the market in 2026.
India and China are identified as significant growth markets, with projected CAGRs of 9.6% and 8.8%, respectively. The demand for these products is further amplified by a growing understanding among pet owners about dental health, leading to earlier diagnoses and treatment initiation.
The analysis indicates that North America remains a leading market due to its established healthcare systems and payer coverage, while Europe and Asia Pacific are also expected to show steady growth. The competitive landscape includes major players such as Virbac S.A., Colgate-Palmolive, and Dechra Pharmaceuticals, all of whom are capitalizing on regulatory approvals and expanding their product offerings to meet rising demand.
Shambhu Nath Jha, Principal Consultant at Fact.MR, noted that the next phase of growth will depend on geographic expansion and real-world evidence generation, particularly in mid-income markets.